Voyager struggles with a negative enterprise value, financial risks, and limited catalysts in a competitive Alzheimer's ...

Patients with Alzheimer disease and cognitive impairment with delayed REM sleep patterns have increased levels of brain amyloid and tau.

Plasma biomarkers show potential in detecting and monitoring Alzheimer's pathology in preclinical stages, aiding early ...

Frontotemporal Dementia (FTD) has long stood apart from Alzheimer’s disease-rarer, younger in onset, and devoid of any ...

Dr. Richard G. Stefanacci explains why the FDA's recent clearance of a diagnostic blood test for Alzheimer's deserves ...

Advances in tau biomarker detection have introduced several technological platforms. Tau positron emission tomography (Tau-PET) imaging remains the gold standard for confirming neurofibrillary tangle ...

Researchers from The University of Texas at Dallas' Center for Vital Longevity (CVL) have released the full dataset from a ...

It was 2006 when Dr. Daniel Gibbs first noticed he was losing his sense of smell. But it wasn't what he didn't smell that ...

In TANGO, gosuranemab wasn't able to show an impact on tangles in the brain measured using tau-PET scans – despite clearing the protein out of the CSF – which might point to one possible ...

Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in ...